Scholars Central

Conference abstractPublished 28 May 2022

Filamentous fungi as l-asparaginase producers.

Authors: Edvaldo A. R. Rosa

Journal of Molecular Microbiology

Volume 6 · Issue 3 · Pages 2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Patients with acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), some types of non-Hodgkin's lymphoma (nhl) and breast carcinona can be treated with L-asparaginase (L-asnase; EC 3.5.1.1), an enzyme of microbial origin that efficiently reduces the availability of L-asparagine to cancer cells, unable to synthesize the amino acid. The commercial production of L-asnase via bioprocesses involves the Gram-negative bacillus Erwinia chrysanthemi and other Enterobacteriaceae. However, bacterial enzymes can provoke hypersensitivity reactions. Also, their L-glutaminase-like activity can drive to neuronal disorders. These unfavorable characteristics have led to the prospection of new L-asnases in eukaryotic microorganisms and an international effort has been made to seek such enzymes, especially in filamentous fungi from different sources. This presentation reviews the potential of many L-asnase-producing fungi for the obtaining of an effective and low-cost medicament for the above-mentioned cancers.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Microbiology
  • SubjectGenetics & Molecular Biology
  • SubjectMicrobiology
  • BylineArticles whose byline prints “Edvaldo A. R. Rosa”